The Structure, Function, and Evaluation of the Female Reproductive Tract

Yen & Jaffe's Reproductive Endocrinology

Volumn , Issue , 2009, Pages 191-233

  Strauss, Jerome F ^a   Lessey, Bruce A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884109137     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4907-4.00009-7     Document Type: Chapter

References (455)

1. O'Rahilly R. Prenatal human development. Biology of the Uterus 1989, 35-56. Plenum, New York. R.M. Wynn, W.P. . Jolie (Eds.).
2. Gray C.A., Bartol F.F., Tarleton B.J., et al. Developmental biology of uterine glands. Biol Reprod 2001, 65:1311-1323.
3. Szamborski J., Laskowska H. Some observations on the developmental histology of the human foetal uterus. Biol Neonat 1968, 13:298-314.
4. Heikkila M., Peltoketo H., Vainio S. Wnts and the female reproductive system. J Exp Zool 2001, 290:616-623.
5. Vainio S., Heikkila M., Kispert A., et al. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999, 397:405-409.
6. Taylor H.S., Vanden Heuvel G.B., Igarashi P. A conserved Hox Axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997, 57:1338.
7. Morcel K., Camborieux L., Guerrier D. Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Orphanet J Rare Dis 2007, 2:13.
8. Timmreck L.S., Pan H.A., Reindollar R.H., et al. WNT7A mutations in patients with mullerian duct abnormalities. J Pediatr Adolesc Gynecol 2003, 16:217-221.
9. Deutscher E., Hung-Chang Yao H. Essential roles of mesenchyme-derived beta-catenin in mouse mullerian duct morphogenesis. Dev Biol 2007, 307:227-236.
10. Parr B.A., McMahon A.P. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998, 395:707-710.
11. Miller C., Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 1998, 125:3201-3211.
12. Tulac S., Overgaard M.T., Hamilton A.E., et al. Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab 2006, 91:1453-1461.
13. Tulac S., Nayak N.R., Kao L.C., et al. Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 2003, 88:3860-3866.
14. Vitiello D., Kodaman P.H., Taylor H.S. HOX genes in implantation. Semin Reprod Med 2007, 25:431-436.
15. Innis J.W., Goodman F.R., Bacchelli C., et al. A HOXA13 allele with a missense mutation in the homeobox and a dinucleotide deletion in the promoter underlies Guttmacher syndrome. Hum Mutat 2002, 19:573-574.
16. Goodman F.R., Bacchelli C., Brady A.F., et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 2000, 67:197-202.
17. Hsieh-Li H.M., Witte D.P., Weinstein M., et al. Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development 1995, 121:1373-1385.
18. Wang W., Van De Water T., Lufkin T. Inner ear and maternal reproductive defects in mice lacking the Hmx3 homeobox gene. Development 1998, 125:621-634.
19. Bartol F.F., Wiley A.A., Bagnell C.A. Uterine development and endometrial programming. Soc Reprod Fertil Suppl 2006, 2:113-130.
20. Kobayashi A., Shawlot W., Kania A., et al. Reguirement of Lim1 for female reproductive tract development. Development 2004, 131:539-549.
21. Torres M., Gomez-Pardo E., Dressler G.R., et al. Pax-2 controls multiple steps of urogenital development. Development 1995, 121:4057-4065.
22. Miyamoto N., Yoshida M., Kuratani S., et al. Defects of urogenital development in mice lacking Emx2. Development 1997, 124:1653-1664.
23. Couse J.F., Hewitt S.C., Bunch D.O., et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999, 286:2328-2331.
24. Greco T.L., Duello T.M., Gorski J. Estrogen receptors, estradiol, and diethylstilbestrol in early development: the mouse as a model for the study of estrogen receptors and estrogen sensitivity in embryonic development of male and female reproductive tracts. Endocr Rev 1993, 14:59-71.
25. Block K., Kardana A., Igarashi P., et al. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J 2000, 14:1101-1108.
26. Cunha G.R., Chung L.W., Shannon J.M., et al. Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog Horm Res 1983, 39:559-598.
27. Cooke P.S., Buchanan D.L., Young P., et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A 1997, 94:6535-6540.
28. Kurita T., Lee K., Cooke P.S., et al. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus. Biol Reprod 2000, 62:831-838.
29. Glatstein I.Z., Yeh J. Ontogeny of the estrogen receptor in the human fetal uterus. J Clin Endocrinol Metab 1995, 80:958-964.
30. Yeh J., Thiet M.-P., Laohaprasitiporn C., et al. Growth factors in the fetal uterus. Semin Reprod Med 1995, 13:102.
31. Press M.F., Udove J.A., Greene G.L. Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol 1988, 131:112-124.
32. Press M.F., Nousek Goebl N.A., Bur M., et al. Estrogen receptor localization in the female genital tract. Am J Pathol 1986, 123:280-292.
33. Lessey B.A., Killam A.P., Metzger D.A., et al. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988, 67:334-340.
34. Brenner R.M., West N.B., McClellan M.C. Estrogen and progestin receptors in the reproductive tract of male and female primates. Biol Reprod 1990, 42:11-19.
35. Gregory C.W., Wilson E.M., Apparao K.B., et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 2002, 87:2960-2966.
36. Han S.J., DeMayo F.J., Xu J., et al. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol Endocrinol 2006, 20:45-55.
37. Revankar C.M., Cimino D.F., Sklar L.A., et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
38. Hewitt S.C., Deroo B.J., Korach K.S. Signal transduction: a new mediator for an old hormone?. Science 2005, 307:1572-1573.
39. Akingbemi B.T., Ge R., Rosenfeld C.S., et al. Estrogen receptor-alpha gene deficiency enhances androgen biosynthesis in the mouse Leydig cell. Endocrinology 2003, 144:84-93.
40. Matsuzaki S., Fukaya T., Suzuki T., et al. Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 1999, 5:559-564.
41. Critchley H.O.D., Brenner R.M., Drudy T.A., et al. Estrogen receptor β, but not estrogen receptor α, is present in the vascular endometrium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001, 86:1370-1378.
42. Tan J., Paria B.C., Dey S.K., et al. Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse. Endocrinology 1999, 140:5310-5321.
43. Lessey B.A., Palomino W.A., Apparao K.B., et al. Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol 2006, 4(Suppl 1):S9.
44. Critchley H.O., Henderson T.A., Kelly R.W., et al. Wild-type estrogen receptor (ERbeta1) and the splice variant (ERbetacx/beta2) are both expressed within the human endometrium throughout the normal menstrual cycle. J Clin Endocrinol Metab 2002, 87:5265-5273.
45. Lubahn D.B., Moyer J.S., Golding T.S., et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993, 90:11162-11166.
46. Krege J.H., Hodgin J.B., Couse J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci U S A 1998, 95:15677-15682.
47. Cowley S.M., Parker M.G. A comparison of transcriptional activation by ERa and ERb. J Steroid Biochem Mol Biol 1999, 69:165-175.
48. Key T.J., Pike M.C. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988, 57:205-212.
49. Ogle T.F. Progesterone-action in the decidual mesometrium of pregnancy. Steroids 2002, 67:1-14.
50. Lydon J.P., DeMayo F.J., Funk C.R., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278.
51. Conneely O.M., Mulac-Jericevic B., DeMayo F., et al. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002, 57:339-355.
52. Edwards D.P. Progesterone receptor structure/function and crosstalk with cellular signaling pathways. Encyclopedia of Hormones 2004, 8-22. Academic Press, San Diego. H.L. Henry, A.W. Norman (Eds.).
53. Lim C.S., Baumann C.T., Hutun H., et al. Differential localization and activity of the A- and B- forms of human progesterone receptor using green fluorescent protein chimeras. Mol Endocrinol 1999, 13:366-375.
54. Arnett-Mansfield R.L., DeFazio A., Mote P.A., et al. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium. J Clin Endocrinol Metab 2004, 89:1429-1442.
55. Boonyaratanakornkit V., McGowan E.J., Sherman L., et al. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and cell cycle. Mol Endocrinol 2007, 11:495-503.
56. Levy C.E., Robel P., Gautray J.P., et al. Estradiol and progesterone receptors in human endometrium: normal and abnormal menstrual cycles and early pregnancy. Am J Obstet Gynecol 1980, 136:646-651.
57. Mote P.A., Balleine R.L., McGowan E.M., et al. Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma. Hum Reprod 2000, 15(Suppl 3):48-56.
58. Igarashi T.M., Bruner-Tran K.L., Yeaman G.R., et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril 2005, 84:67-74.
59. Ferenczy A., Bertrand G., Gelfand M. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979, 133:859-867.
60. Bigsby R.M. Control of growth and differentiation of the endometrium: the role of tissue interactions. Ann N Y Acad Sci 955:110-117. discussion 2002, 118:396-406.
61. Kurita T., Young P., Brody J.R., et al. Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis. Endocrinology 1998, 139:4708-4713.
62. Pierro E., Minici F., Alesiani O., et al. Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium. Biol Reprod 2001, 64:831-838.
63. Dickson R.B., Lippman M.E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 1987, 8:29-43.
64. Hom Y.K., Young P., Wiesen J.F., et al. Uterine and vaginal organ growth requires epidermal growth factor receptor signaling from stroma. Endocrinology 1998, 139:913-921.
65. Ritvos O., Ranta T., Jalkanen J., et al. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 1988, 122:2150-2157.
66. Ghahary A., Murphy L.J. Uterine insulin-like growth factor-I receptors: regulation by estrogen and variation throughout the estrous cycle. Endocrinology 1989, 125:597-604.
67. Carlsson B., Billig H. Insulin-like growth factor-I gene expression during development and estrous cycle in the rat uterus. Mol Cell Endocrinol 1991, 77:175-180.
68. Rajkumar K., Krsek M., Dheen S.T., et al. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 1996, 98:1818-1825.
69. Sato T., Wang G., Hardy M.P., et al. Role of systemic and local IGF-I in the effects of estrogen on growth and epithelial proliferation of mouse uterus. Endocrinology 2002, 143:2673-2679.
70. Adesanya-Famuyiwa O.O., Zhou J., Wu G., et al. Localization and sex steroid regulation of androgen receptor gene expression in rhesus monkey uterus. Obstet Gynecol 1999, 93:265-270.
71. Ito K., Suzuki T., Akahira J., et al. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders. Int J Cancer 2002, 99:652-657.
72. Apparao K.B., Lovely L.P., Gui Y., et al. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 2002, 66:297-304.
73. Pedram A., Razandi M., Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 2006, 20:1996-2009.
74. Ahola T.M., Manninen T., Alkio N., et al. G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells. Endocrinology 2002, 143:3376-3384.
75. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr Rev 2007, 28:726-741.
76. Filardo E.J., Quinn J.A., Bland K.I., et al. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
77. Filardo E.J., Quinn J.A., Frackelton A.R., et al. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002, 16:70-84.
78. Filardo E.J., Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005, 16:362-367.
79. Ahola T.M., Purmonen S., Pennanen P., et al. Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells. Eur J Biochem 2002, 269:2485-2490.
80. Boonyaratanakornkit V., Edwards D.P. Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med 2007, 25:139-153.
81. Zhu Y., Bond J., Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A 2003, 100. 2247-2242.
82. Karteris E., Zervou S., Pang Y. Progesterone signaling in human myometrium through two novel membrane G protein-coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 2006, 20:1519-1534.
83. Gurpide E. Enzymatic modulation of hormonal action at the target tissue. J Toxicol Environ Health 1978, 4:249-268.
84. Tseng L., Mazella J. Cyclic changes of estradiol metabolic enzymes in human endometrium during the menstrual cycle 1980, SP Medical and Scientific Books.
85. Tseng L., Mazella J. Cyclic change of estradiol metabolic enzyme in human endometrium during menstrual cycle. The Endometrium. 1980, 211-225. SP Medical and Scientific Books, New York. F. Kimball (Ed.).
86. Husen B., Adamski J., Rune G.M., et al. Mechanisms of estradiol inactivation in primate endometrium. Mol Cell Endocrinol 2001, 171:179-185.
87. Ezaki K., Motoyama H., Sasaki H. Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol 2001, 98:815-819.
88. Bulun S.E., Cheng Y.H., Yin P., et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 2006, 248:94-103.
89. Leon L., Bacallao K., Gabler F., et al. Activities of steroid metabolic enzymes in secretory endometria from untreated women with polycystic ovary syndrome. Steroids 2007, 73:88-95.
90. Zeitoun K.M., Bulun S.E. Aromatase: a key molecule in the pathophysiology of endmetriosis and a therapeutic target. Fertil Steril 1999, 72:961-969.
91. Tsai S.J., Wu M.H., Lin C.C., et al. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 2001, 86:5765-5773.
92. Attia G.R., Zeitoun K., Edwards D., et al. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000, 85:2897-2902.
93. Fazleabas A.T., Brudney A., Chai D., et al. Steroid receptor and aromatase expression in baboon endometriotic lesions. Fertil Steril 2003, 80(Suppl 2):820-827.
94. Hudelist G., Keckstein J., Czerwenka K., et al. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril 2005, 80(Suppl 2):1249-1256.
95. Meresman G.F., Vighi S., Buquet R.A., et al. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 2000, 74:760-766.
96. Dmowski W.P., Ding J., Shen J., et al. Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis. Hum Reprod 2001, 16:1802-1808.
97. Croxatto H.B. Physiology of gamete and embryo transport through the fallopian tube. Reprod Biomed Online 2002, 4:160-169.
98. Gordts S., Campo R., Rombauts L., et al. Endoscopic visualization of the process of fimbrial ovum retrieval in the human. Hum Reprod 1998, 13:1425-1428.
99. Diaz S., Ortiz M.E., Croxatto H.B. Studies on the duration of ovum transport by the human oviduct: III. Time interval between the luteinizing hormone peak and recovery of ova by transcervical flushing of the uterus in normal women. Am J Obstet Gynecol 1980, 137:116-121.
100. Vizza E., Correr S., Muglia U., et al. The three-dimensional organization of the smooth musculature in the ampulla of the human fallopian tube: a new morpho-functional model. Hum Reprod 1995, 10:2400-2405.
101. Huang J.C., Arbab F., Tumbusch K.J., et al. Human fallopian tubes express prostacyclin (PGI) synthase and cyclooxygenases and synthesize abundant PGI. J Clin Endocrinol Metab 2002, 87:4361-4368.
102. Pacey A.A., Hill C.J., Scudamore I.W., et al. The interaction in vitro of human spermatozoa with epithelial cells from the human uterine (fallopian) tube. Hum Reprod 1995, 10:360-366.
103. Verhage H.G., Bareither M.L., Jaffe R.C., et al. Cyclic changes in ciliation, secretion and cell height of the oviductal epithelium in women. Am J Anat 1979, 156:505-521.
104. Greenstone M., Rutman A., Dewar A., et al. Primary ciliary dyskinesia: cytological and clinical features. Q J Med 1988, 67:405-423.
105. Afzelius B.A., Camner P., Mossberg B. On the function of cilia in the female reproductive tract. Fertil Steril 1978, 29:72-74.
106. Leese H.J., Tay J.I., Reischl J., et al. Formation of fallopian tubal fluid: role of a neglected epithelium. Reproduction 2001, 121:339-346.
107. Tay J.I., Rutherford A.J., Killick S.R., et al. Human tubal fluid: production, nutrient composition and response to adrenergic agents. Hum Reprod 1997, 12:2451-2456.
108. Gardner D.K., Lane M., Calderon I., et al. Environment of the preimplantation human embryo in vivo: metabolite analysis of oviduct and uterine fluids and metabolism of cumulus cells. Fertil Steril 1996, 65:349-353.
109. Gardner D.K., Vella P., Lane M., et al. Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril 1998, 69:84-88.
110. Devreker F., Englert Y. In vitro development and metabolism of the human embryo up to the blastocyst stage. Eur J Obstet Gynecol Reprod Biol 2000, 92:51-56.
111. Buhi W.C. Characterization and biological roles of oviduct-specific, oestrogen-dependent glycoprotein. Reproduction 2002, 123:355-362.
112. Gargett C.E., Chan R.W., Schwab K.E. Endometrial stem cells. Curr Opin Obstet Gynecol 2007, 19:377-383.
113. Kao L.C., Germeyer A., Tulac S., et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003, 144:2870-2881.
114. Burney R.O., Talbi S., Hamilton A.E., et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007, 148:3814-3826.
115. Slayden O.D., Keator C.S. Role of progesterone in nonhuman primate implantation. Semin Reprod Med 2007, 25:418-430.
116. Wynn R.M. Histology and ultrastructure of the human endometrium. Biology of the Uterus 1977, 341-347. Plenum, New York. R.M. Wynn, W.P. Jolie (Eds.).
117. Isaac C., Pollard J.W., Meier U.T. Intranuclear endoplasmic reticulum induced by Nopp140 mimics the nucleolar channel system of human endometrium. J Cell Sci 2001, 114:4253-4264.
118. King A. Uterine leukocytes and decidualization. Hum Reprod Update 2000, 6:28-36.
119. Aplin J.D., Charlton A.K., Ayad S. An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy. Cell Tissue Res 1988, 253:231.
120. Iwahashi M., Muragaki Y., Ooshima A., et al. Alterations in distribution and composition of the extracellular matrix during decidualization of the human endometrium. J Reprod Fertil 1996, 108:147-155.
121. Brar A.K., Handwerger S., Kessler C.A., et al. Gene induction and categorical reprogramming during in vitro human endometrial fibroblast decidualization. Physiol Genomics 2001, 7:135-148.
122. Schatz F., Aigner S., Papp C., et al. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1. J Clin Endocrinol Metab 1995, 80:2504-2510.
123. Lockwood C.J., Runic R., Wan L., et al. The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception. Hum Reprod 2000, 15(Suppl 3):144-151.
124. Salamonsen L.A., Lathbury L.J. Endometrial leukocytes and menstruation. Hum Reprod Update 2000, 6:16-27.
125. Curry T.E., Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003, 24:428-465.
126. Markee J.E. Menstruation in intraocular endometrial transplants in the Rhesus monkey. Am J Obstet Gynecol 1978, 131:558-559.
127. Fraser I.S., McCarron G., Hutton B., et al. Endometrial blood flow measured by xenon 133 clearance in women with normal menstrual cycles and dysfunctional uterine bleeding. Am J Obstet Gynecol 1987, 156:158-166.
128. Zhang J., Salamonsen L.A. Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum Reprod 2002, 17:265-274.
129. Marbaix E., Kokorine I., Moulin P., et al. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci U S A 1996, 93:9120-9125.
130. Rodgers W.H., Matrisian L.M., Giudice L.C., et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994, 94:946-953.
131. Irwin J.C., Kirk D., Gwatkin R.B.L., et al. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase: hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 1996, 97:438-447.
132. Henriet P., Cornet P.B., Lemoine P., et al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs). Ann N Y Acad Sci 955:119-138. discussion 2002, 157-118:396-406.
133. Otsuki Y. Apoptosis in human endometrium: apoptotic detection methods and signaling. Med Electron Microsc 2001, 34:166-173.
134. Kokawa K., Shikone T., Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 1996, 81:4144-4147.
135. Konno R., Yamakawa H., Utsunomiya H., et al. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 2000, 6:529-534.
136. Lessey B.A., Lovely L.P., McAdams D., et al. Randomized prospective comparison of hCG versus progesterone to prevent apoptosis in late luteal phase endometrium. J Clin Endocrinol Metab 2000, 2:50.
137. Ueda M., Yamashita Y., Takehara M., et al. Survivin gene expression in endometriosis. J Clin Endocrinol Metab 2002, 87:3452.
138. Kodaman P.H., Arici A. Intra-uterine adhesions and fertility outcome: how to optimize success?. Curr Opin Obstet Gynecol 2007, 19:207-214.
139. Gargett C.E., Rogers P.A. Human endometrial angiogenesis. Reproduction 2001, 121:181-186.
140. Smith S.K. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update 1998, 4:509-519.
141. Krikun G., Schatz F., Lockwood C.J. Endometrial angiogenesis: from physiology to pathology. Ann N Y Acad Sci 2004, 1034:27-35.
142. Gambino L.S., Wreford N.G., Bertram J.F., et al. Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. Hum Reprod 2002, 17:1199-1206.
143. Koga K., Osuga Y., Tsutsumi O., et al. Demonstration of angiogenin in human endometrium and its enhanced expression in endometrial tissues in the secretory phase and the decidua. J Clin Endocrinol Metab 2001, 86:5609-5614.
144. Ancelin M., Buteau-Lozano H., Meduri G., et al. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proc Natl Acad Sci U S A 2002, 99:6023-6028.
145. Moller B., Rasmussen C., Lindblom B., et al. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 2001, 7:65-72.
146. Sugino N., Kashida S., Takiguchi S., et al. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2000, 85:3919-3924.
147. Krussel J.S., Casan E.M., Raga R., et al. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol Hum Reprod 2001, 5:452-458.
148. Meduri G., Bausero P., Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol Reprod 2000, 62:439-447.
149. Graubert M.D., Ortega M.A., Kessel B., et al. Vascular repair after menstruation involves regulation of vascular endothelial growth factor-receptor phosphorylation by sFLT-1. Am J Pathol 2001, 158:1399-1410.
150. Brooks P.C., Clark R.A.F., Cheresh D.A. Requirement of vascular integrin alpha v/beta 3 for angiogenesis. Science 1994, 264:569-571.
151. Hewett P., Nijjar S., Shams M., et al. Down-regulation of angiopoietin-1 expression in menorrhagia. Am J Pathol 2002, 160:773-780.
152. Gannon B.J., Verco C.J., Carati C.J. Human endometrial perfusion after tubal occlusion. Hum Reprod 1998, 13:445-449.
153. Casslen B., Andersson A., Nilsson I.M., et al. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture. Proc Soc Exp Biol Med 1986, 182:419-424.
154. Rudolph-Owen L.A., Slayden O.D., Matrisian L.M., et al. Matrix metalloproteinase expression in Macaca mulatta endometrium: evidence for zone-specific regulatory tissue gradients. Biol Reprod 1998, 59:1349-1359.
155. Tabibzadeh S. Role of EBAF/Lefty in implantation and uterine bleeding. Ernst Schering Res Found Workshop 2005, 159-189.
156. Kothapalli R., Buyuksal I., Wu S.Q., et al. Detection of ebaf, a novel human gene of the transforming growth factor β superfamily: association of gene expression with endometrial bleeding. J Clin Invest 1997, 99:2342-2350.
157. Tabibzadeh S., Lessey B., Satyaswaroop P.G. Temporal and site-specific expression of transforming growth factor-beta4 in human endometrium. Mol Hum Reprod 1998, 4:595-602.
158. Tabibzadeh S., Mason J.M., Shea W., et al. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab 2000, 85:2526-2536.
159. Cornet P.B., Picquet C., Lemoine P., et al. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloprotineases. J Biol Chem 2002, 277:42496-42504.
160. Jokimaa V., Oksjoki S., Kujari H., et al. Expression patterns of cathepsins B, H, K, L and S in the human endometrium. Mol Hum Reprod 2001, 7:73-78.
161. Akerlund A. Vascularization of human endometrium: uterine blood flow in healthy condition and in primary dysmenorrhoea. Ann N Y Acad Sci 1994, 734:47-55.
162. Bieglmayer C., Hofer G., Kainz C., et al. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 1995, 9:307-312.
163. Casey M.L., Hemsell D.L., MacDonald P.C., et al. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in human endometrium. Prostaglandins 1980, 19:115-122.
164. Lockwood C.J. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Am J Obstet Gynecol 2001, 184:798-804. discussion 804-795.
165. Papp C., Schatz F., Krikun G., et al. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium. Early Pregnancy 2000, 4:230-239.
166. Hertig A.T., Rock J., Adams E.C. A description of 34 human ova within the first 17 days of development. Am J Anat 1956, 98:435-493.
167. Mazur M.T., Duncan D.A., Younger J.B. Endometrial biopsy in the cycle of conception: histologic and lectin histochemical evaluation. Fertil Steril 1989, 51:764-769.
168. Thrasher T.V., Richart R.M. Ultrastructure of the Arias-Stella reaction. Am J Obstet Gynecol 1972, 112:113-120.
169. Arias-Stella J. The Arias-Stella reaction: facts and fancies four decades after. Adv Anat Pathol 2002, 9:12-23.
170. Irwin J.C., Suen L.F., Martina N.A., et al. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1999, 14(Suppl 2):90-96.
171. Irwin J.C., Giudice L.C. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast α5β1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res 1998, 8:21:31.
172. Williams C.D., Boggess J.F., LaMarque L.R., et al. A prospective, randomized study of endometrial telomerase during the menstrual cycle. J Clin Endocrinol Metab 2001, 86:3912-3917.
173. Curtis K.M., Hillis S.D., Marchbanks P.A., et al. Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol 2002, 187:543-544.
174. Hafez E.S. Transport of spermatozoa in the female reproductive tract. Am J Obstet Gynecol 1973, 115:703-717.
175. Gipson I.K. Mucins of the human endocervix. Front Biosci 2001, 6:D1245-D1255.
176. Lagow E., DeSouza M.M., Carson D.D. Mammalian reproductive tract mucins. Hum Reprod Update 1999, 5:280-292.
177. Croxatto H.B. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 2002, 65:21-27.
178. Togashi K., Nakai A., Sugimura K. Anatomy and physiology of the female pelvis: MR imaging revisited. J Magn Reson Imaging 2001, 13:842-849.
179. Chalubinski K., Deutinger J., Bernaschek G. Vaginosonography for recording of cycle-related myometrial contractions. Fertil Steril 1993, 59:225-228.
180. Kunz G., Beil D., Deininger H., et al. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996, 11:627-632.
181. Ijland M.M., Evers J.L., Dunselman G.A., et al. Relation between endometrial wavelike activity and fecundability in spontaneous cycles. Fertil Steril 1997, 67:492-496.
182. Bulletti C., de Ziegler D. Uterine contractility and embryo implantation. Curr Opin Obstet Gynecol 2006, 18:473-484.
183. Ijland M.M., Hoogland H.J., Dunselman G.A.J., et al. Endometrial wave direction switch and the outcome of in vitro fertilization. Fertil Steril 1999, 71:476.
184. Leyendecker G., Kunz G., Wildt L., et al. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 1996, 11:1542-1551.
185. Salamanca A., Beltran E. Subendometrial contractility in menstrual phase visualized by transvaginal sonography in patients with endometriosis. Fertil Steril 1995, 64:193-195.
186. Bulletti C., de Ziegler D., Polli V., et al. Characteristics of uterine contractility during menses in women with mild to moderate endometriosis. Fertil Steril 2002, 77:1156-1161.
187. Whitelaw P.F., Croy B.A. Granulated lymphocytes of pregnancy. Placenta 1996, 17:533-543.
188. Lea R.G., Sandra O. Immunoendocrine aspects of endometrial function and implantation. Reproduction 2007, 134:389-404.
189. Givan A.L., White H.D., Stern J.E., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 1997, 38:350-359.
190. Hannan N.J., Salamonsen L.A. Role of chemokines in the endometrium and in embryo implantation. Curr Opin Obstet Gynecol 2007, 19:266-272.
191. Ma Z., Lu F.X., Torten M., et al. The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clin Immunol 2001, 100:240-249.
192. Jabbour H.N., Critchley H.O. Potential roles of decidual prolactin in early pregnancy. Reproduction 2001, 121:197-205.
193. Dosiou C., Giudice L.C. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005, 26:44-62.
194. Brackin M.N., Cruse J.M., Lewis R.E., et al. Quantitative analysis of adhesion molecules on cellular constituents of the human uterine microenvironment under the influence of estrogen and progesterone. Exp Mol Pathol 2002, 72:91-114.
195. Hasty L.A., Lambris J.D., Lessey B.A., et al. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol 1994, 170:168-175.
196. Isaacson K.B., Galman M., Coutifaris C., et al. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis. Fertil Steril 1990, 53:836-841.
197. Jensen T.S., Bjorge L., Wollen A.L., et al. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion. Am J Reprod Immunol 1995, 34:1-9.
198. Young S.L., Lessey B.A., Fritz M.A., et al. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab 2002, 87:1368-1375.
199. Isaacson K.B., Galman M., Coutifaris C., et al. Endometrial synthesis and secretion of complement component-3 by patients with and without endometriosis. Fertil Steril 1990, 53:836-841.
200. Xu C., Mao D., Holers V.M., et al. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000, 287:498-501.
201. Holers V.M., Girardi G., Mo L., et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195:211-220.
202. Salmon J.E., Girardi G., Holers V.M. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis 2003, 61(Suppl 2):46-50.
203. Thurman J.M., Kraus D.M., Girardi G., et al. A novel inhibitor of the alternative complement pathway prevents anti-phosphoslipid antibody-induced pregnancy loss in mice. Mol Immununol 2005, 42:87-97.
204. King A.E., Fleming D.C., Critchley H.O., et al. Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod 2002, 8:341-349.
205. Quayle A.J., Porter E.M., Nussbaum A.A., et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol 1998, 152:1247-1258.
206. Seppäla M., Suikkari A.M., Julkunen M. Human endometrial proteins. Reprod Nutr Dev 1988, 28:1649-1654.
207. Carson D.D., Bagchi I., Dey S.K., et al. Embryo implantation. Dev Biol 2000, 223:217-237.
208. Finn C.A., Martin L. The control of implantation. J Reprod Fertil 1974, 39:195-206.
209. Psychoyos A. Hormonal control of ovoimplantation. Vitam Horm 1973, 31:201-256.
210. Psychoyos A. Uterine receptivity for nidation. Ann N Y Acad Sci 1986, 476:36-42.
211. Pope W.F. Uterine asynchrony: a cause of embryonic loss. Biol Reprod 1988, 39:999-1003.
212. Paria B.C., Reese J., Das S.K., et al. Deciphering the cross-talk of implantation: advances and challenges. Science 2002, 296:2185-2188.
213. Hodgen G.D. Surrogate embryo transfer combined with estrogen-progesterone therapy in monkeys: implantation, gestation, and delivery without ovaries. JAMA 1983, 250:2167-2171.
214. Navot D., Bergh P. Preparation of the human endometrium for implantation. Ann N Y Acad Sci 1991, 622:212-219.
215. Wilcox A.J., Baird D.D., Wenberg C.R. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999, 340:1796-1799.
216. Cowell T.P. Implantation and development of mouse eggs transferred to the uterus of non-progestational mice. J Reprod Fertil 1969, 19:239-245.
217. Bergh P.A., Navot D. The impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril 1992, 58:537-542.
218. Paria B.C., Song H., Dey S.K. Implantation: molecular basis of embryo-uterine dialogue. Int J Dev Biol 2001, 45:597-605.
219. Zhou Y., Fisher S.J., Janatpour M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion?. J Clin Invest 1997, 99:2139-2151.
220. Langmann T., Mauerer R., Zahn A., et al. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem 2003, 49:230-238.
221. Bell S.C., Patel S.R., Kirwan P.H., et al. Protein synthesis and secretion by the human endometrium during the menstual cycle and the effect of progesterone in vitro. J Reprod Fertil 1986, 77:221-231.
222. Seppäla M., Koistinen R., Rutanen E.M. Uterine endocrinology and paracrinology: insulin-like growth factor binding protein-1 and placental protein 14 revisited. Hum Reprod 1994, 9:917-925.
223. Seppala M., Taylor R.N., Koistinen H., et al. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 2002, 23:401-430.
224. Dell A., Morris H.R., Easton R.L., et al. Structural analysis of the oligosaccarides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem 1995, 270:24116-24126.
225. Oehninger S., Coddington C.C., Hodgen G.D., et al. Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 1995, 63:377-383.
226. Stewart D.R., Erikson M.S., Erikson M.E., et al. The role of relaxin in glycodelin secretion. J Clin Endocrinol Metab 1997, 82:839-846.
227. Klentzeris L.D., Bulmer J.N., Seppala M., et al. Placental protein 14 in cycles with normal and retarded endometrial differentiation. Hum Reprod 1994, 9:394-398.
228. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
229. Takai N., Desmond J.C., Kumagai T., et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin Cancer Res 2004, 10:1141-1149.
230. Uchida H., Maruyama T., Ohta K., et al. Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation. Hum Reprod 2007, 22:2615-2622.
231. Jakubowicz D.J., Essah P.A., Seppala M., et al. Reduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancy. J Clin Endocrinol Metab 2004, 89:833-839.
232. Raymond E.G., Lovely L.P., Chen-Mok M., et al. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000, 15:2351-2355.
233. Mandelin E., Koistinen H., Koistinen R., et al. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?. Hum Reprod 1997, 12:2671.
234. Giudice L.C. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 1994, 61:1-17.
235. Crossey P.A., Pillai C.C., Miell J.P. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 2002, 110:411-418.
236. Gleeson L.M., Chakraborty C., McKinnon T., et al. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway. J Clin Endocrinol Metab 2001, 86:2484-2493.
237. Thraikill K.M., Clemmons D.R., Busby W.H., et al. Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin. J Clin Invest 1990, 86:878-883.
238. Gao J., Mazella J., Tseng L. Activation of the human IGFBP-1 gene promoter by progestin and relaxin in primary culture of human endometrial stromal cells. Mol Cell Biol 1994, 104:29-46.
239. Tazuke S.I., Mazure N.M., Sugawara J., et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci U S A 1998, 95:10188-10193.
240. Kim J.J., Taylor H.S., Akbas G.E., et al. Regulation of insulin-like growth factor binding protein-1 promoter activity by FKHR and HOXA10 in primate endometrial cells. Biol Reprod 2003, 68:24-30.
241. Licht P., Russu V., Lehmeyer S., et al. Intrauterine microdialysis reveals cycle-dependent regulation of endometrial insulin-like growth factor binding protein-1 secretion by human chorionic gonadotropin. Fertil Steril 2002, 78:252-258.
242. Savaris RF, Hamilton AE, Lessey BA, et al. Endometrial gene expression in early pregnancy: lessons from human ectopic pregnancy. Reprod Sci 2008, 15:797-816.
243. Kim J.J., Taylor H.S., Lu Z., et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod 2007, 13:323-332.
244. Jain A., Karadag A., Fohr B., et al. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J Biol Chem 2002, 277:13700-13708.
245. Fisher L.W., Torchia D.A., Fohr B., et al. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun 2001, 280:460-465.
246. Apparao K.B., Murray M.J., Fritz M.A., et al. Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 2001, 86:4991-5000.
247. Johnson G.A., Spencer T.E., Burghardt R.C., et al. Progesterone modulation of osteopontin gene expression in the ovine uterus. Biol Reprod 2000, 62:1315-1321.
248. Fedarko N.S., Fohr B., Robey P.G., et al. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 2000, 275:16666-16672.
249. Maslar I.A., Ansbacher R. Effects of progesterone on decidual prolactin production by organ cultures of human endometrium. Endocrinology 1986, 118:2102-2108.
250. Kauma S., Shapiro S.S. Immunoperoxidase localization of prolactin in endometrium during normal menstrual, luteal phase defect, and corrected luteal phase defect cycles. Fertil Steril 1986, 46:37-41.
251. Ohata Y., Harada T., Fujii A., et al. Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M. Mol Hum Reprod 2001, 7:665-670.
252. Tennekoon K.H., Eswaramohan T., Karunanayake E.H. Effect of leptin on prolactin and insulin-like growth factor-I secretion by cultured rat endometrial stromal cells. Fertil Steril 2007, 88:193-199.
253. Eyal O., Jomain J.B., Kessler C., et al. Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin. Biol Reprod 2007, 76:777-783.
254. Tawadros N., Salamonsen L.A., Dimitriadis E., et al. Facilitation of decidualization by locally produced ghrelin in the human endometrium. Mol Hum Reprod 2007, 13:483-489.
255. Kutsukake M., Ishihara R., Yoshie M., et al. Involvement of insulin-like growth factor-binding protein-related protein 1 in decidualization of human endometrial stromal cells. Mol Hum Reprod 2007, 13:737-743.
256. Yoshioka H., Harada T., Iwabe T., et al. Menstrual cycle-specific inhibition of the proliferation of endometrial stromal cells by interleukin 6 and its soluble receptor. Am J Obstet Gynecol 1999, 180:1088-1094.
257. Reese J., Binart N., Brown N., et al. Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. Endocrinology 2000, 141:1872-1881.
258. Jabbour H.N., Gubbay O., Chritchley H.O. Prolactin action and signalling in the human endometrium. Reprod Med Rev 2002, 10:117-132.
259. Jones R.L., Stoikos C., Findlay J.K., et al. TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction 2006, 132:217-232.
260. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
261. Adams J.C., Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development 1993, 117:1183-1198.
262. Turpeenniemi-Hujanen T., Feinberg R.F., Kauppila A., et al. Extracellular matrix interactions in early human embryos: implications for normal implantation events. Fertil Steril 1995, 64:132-138.
263. Santala P., Heino J. Regulation of integrin-type cell adhesion receptors by cytokines. J Biol Chem 1991, 266:23505-23509.
264. Sporn M.B., Roberts A.B., Wakefield L.M., et al. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987, 105:1039-1045.
265. Sporn M.B., Roberts A.B., Wakefield L.M., et al. Transforming growth factorβ: biological function and chemical structure. Science 1986, 233:532-534.
266. Godkin J.D., Dore J.J. Transforming growth factor beta and the endometrium. Rev Reprod 1998, 3:1-6.
267. Gaide Chevronnay HP, Cornet PB, Delvaux D, et al. Opposite regulation of transforming growth factors-beta 2 and -beta 3 expression in the human endometrium. Endocrinology 2007, 149:1015-1025.
268. Kulkarni A.B., Thyagarajan T., Letterio J.J. Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2002, 2:303-327.
269. Chegini N., Zhao Y., Williams R.S., et al. Human uterine tissue throughout the menstrual cycle expresses transforming growth factorβ1 (TGF β1), TGF β2, TGF β3, and TGFβ type II receptor messenger ribonucleic acid and protein and contains [125 I]TGFβ1-binding sites. Endocrinology 1994, 135:439-449.
270. Gold L.I., Saxena B., Mittal K.R., et al. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994, 54:2347-2358.
271. Bruner K.L., Rodgers W.H., Gold L.I., et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 1995, 92:7362-7366.
272. Tang M., Taylor H.S., Tabibzadeh S. In vivo gene transfer of lefty leads to implantation failure in mice. Hum Reprod 2005, 20:1772-1778.
273. Tierney E.P., Giudice L.C. Role of activin A as a mediator of in vitro endometrial stromal cell decidualization via the cyclic adenosine monophosphate pathway. Fertil Steril 2004, 81(Suppl 1):899-903.
274. Kauma S., Matt D., Strom S., et al. Interleukin-1 beta, human leukocyte antigen HLA-DR alpha, and transforming growth factor-beta expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol 1990, 163:1430-1437.
275. Feinberg R.F., Kliman H.J., Wang C.L. Transforming growth factorβ stimulates trophoblast oncofetal fibronectin synthesis in vitro: implications for trophoblast implantation in vivo. J Clin Endocrinol Metab 1994, 78:1241-1248.
276. Ignotz R.A., Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986, 261:4337-4345.
277. Ng Y.H., Zhu H., Pallen C.J., et al. Differential effects of interleukin-1beta and transforming growth factor-beta1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro. Hum Reprod 2006, 21:1990-1999.
278. Smalley D.M., Ley K. L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 2005, 9:255-266.
279. Thathiah A., Blobel C.P., Carson D.D. Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem 2003, 278:3386-3394.
280. Thathiah A., Carson D.D. MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17. Biochem J 2004, 382:363-373.
281. Roskoski R. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 2004, 319:1-11.
282. Dey S.K., Lim H., Das S.K., et al. Molecular cues to implantation. Endocr Rev 2004, 25:341-373.
283. Yoo H.J., Barlow D.H., Mardon H.J. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet 1997, 21:102-108.
284. Leach R.E., Kilburn B., Wang J., et al. Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype. Dev Biol 2004, 266:223-237.
285. Raab G., Kover K., Paria B.C., et al. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor. Development 1996, 122:637-645.
286. Das S.K., Wang X.N., Paria B.C., et al. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 1994, 120:1071-1083.
287. Chobotova K., Spyropoulou I., Carver J., et al. Heparin-binding epidermal growth factor and its receptor ErbB4 mediate implantation of the human blastocyst. Mech Dev 2002, 119:137-144.
288. Cullinan E.B., Abbondanzo S.J., Anderson P.S., et al. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci U S A 1996, 93:3115-3120.
289. Irwin J.C., de las Fuentes L., Giudice L.C. Growth factors and decidualization in vitro. Ann N Y Acad Sci 1994, 734:7-18.
290. Fujimoto J., Hori M., Ichigo S., et al. Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle. Gynecol Endocrinol 1996, 10:193-197.
291. Tsai S.J., Wu M.H., Chen H.M., et al. Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology 2002, 143:2715-2721.
292. Clemmons D.R., Underwood L.E. Clinical review 59: uses of human insulin-like growth factor-I in clinical conditions. J Clin Endocrinol Metab 1994, 79:4-6.
293. Giudice L.C., Lamson G., Rosenfeld R.G., et al. Insulin-like growth factor-II (IGF-II) and IGF binding proteins in human endometrium. Ann N Y Acad Sci 1991, 626:295-307.
294. Zhou J., Dsupin B.A., Giudice L.C., et al. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1994, 79:1723-1734.
295. Laatikainen T.J., Tomas E.I., Voutilainen R.J. The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen. Cancer 1995, 76:1406-1410.
296. Hild-Petito S., Verhage H.G., Fazleabas A.T. Characterization, localization, and regulation of receptors for insulin-like growth factor I in the baboon uterus during the cycle and pregnancy. Biol Reprod 1994, 50:791-801.
297. Tazuke S.I., Giudice L.C. Growth factors and cytokines in endometrium, embryonic development, and maternal-embryonic interactions]. Semin Reprod Endocrinol 1996, 14:231-245.
298. Giudice L.C. Multifaceted roles for IGFBP-1 in human endometrium during implantation and pregnancy. Ann N Y Acad Sci 1997, 828:146-156.
299. Hunt J.S., Chen H.L., Hu X.L., et al. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biol Reprod 1992, 47:141-147.
300. Hampson J., McLaughlin P.J., Johnson P.M. Low-affinity receptors for tumour necrosis factor-alpha, interferon-gamma and granulocyte-macrophage colony-stimulating factor are expressed on human placental syncytiotrophoblast. Immunology 1993, 79:485-490.
301. Todt J.C., Yang Y., Lei J. Effects of tumor necrosis factor-alpha on human trophoblast cell adhesion and motility. Am J Reprod Immunol 1996, 36:65-71.
302. Grosskinsky C.M., Yowell C.W., Sun J., et al. Modulation of integrin expression in endometrial stromal cells in vitro. J Clin Endocrinol Metab 1996, 81:2047-2054.
303. Daiter E., Pampfer S., Yeung Y.G., et al. Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab 1992, 74:850-858.
304. Saito S., Saito M., Enomoto M., et al. Human macrophage colony-stimulating factor induces the differentiation of trophoblast. Growth Factors 1993, 9:11-19.
305. Cork B.A., Tuckerman E.M., Li T.C., et al. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro. Mol Hum Reprod 2002, 8:841-848.
306. Cork B.A., Li T.C., Warren M.A., et al. Interleukin-11 (IL-11) in human endometrium: expression throughout the menstrual cycle and the effects of cytokines on endometrial IL-11 production in vitro. J Reprod Immunol 2001, 50:3-17.
307. Lass A., Weiser W., Munafo A., et al. Leukemia inhibitory factor in human reproduction. Fertil Steril 2001, 76:1091-1096.
308. Stewart C.L., Kaspar P., Brunet L.J., et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359:76-79.
309. Chen J.R., Cheng J.G., Shatzer T., et al. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 2000, 141:4365-4372.
310. Stewart C.L. Leukaemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo. Mol Reprod Dev 1994, 39:233-238.
311. Dagoneau N., Scheffer D., Huber C., et al. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am J Hum Genet 2004, 74:298-305.
312. Nachtigall M.J., Kliman H.J., Feinberg R.F., et al. The effect of leukemia inhibitory factor (LIF) on trophoblast differentiation: a potential role in human implantation. J Clin Endocrinol Metab 1996, 81:801-806.
313. Chaouat G., Menu E., Delage G., et al. Immuno-endocrine interactions in early pregnancy. Hum Reprod 1995, 10(Suppl 2):55-59.
314. Charnock-Jones D.S., Sharkey A.M., Fenwick P., et al. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994, 101:421-426.
315. Arici A., Engin O., Attar E., et al. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995, 80:1908-1915.
316. Chen D.B., Hilsenrath R., Yang Z.M., et al. Leukaemia inhibitory factor in human endometrium during the menstrual cycle: cellular origin and action on production of glandular epithelial cell prostaglandin in vitro. Hum Reprod 1995, 10:911-918.
317. Laird S.M., Tuckerman E.M., Dalton C.F., et al. The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 1997, 12:569-574.
318. Ernst M., Inglese M., Waring P., et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001, 194:189-203.
319. Song H., Lim H., Das S.K., et al. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol 2000, 14:1147-1161.
320. Fouladi-Nashta A.A., Jones C.J., Nijjar N., et al. Characterization of the uterine phenotype during the peri-implantation period for LIF-null, MF1 strain mice. Dev Biol 2005, 281:1-21.
321. Gonzalez R.R., Rueda B.R., Ramos M.P., et al. Leptin-induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling. Endocrinology 2004, 145:3850-3857.
322. Jacobs A.L., Carson D.D. Uterine epithelial cell secretion of interleukin-1 alpha induces prostaglandin E2 (PGE2) and PGF2 alpha secretion by uterine stromal cells in vitro. Endocrinology 1993, 132:300-308.
323. Jacobs A.L., Hwang D., Julian J., et al. Regulated expression of prostaglandin endoperoxide synthase-2 by uterine stroma. Endocrinology 1994, 135:1807-1815.
324. Lim H., Dey S.K. PPAR delta functions as a prostacyclin receptor in blastocyst implantation. Trends Endocrinol Metab 2000, 11:137-142.
325. Lim H., Gupta R.A., Ma W.G., et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev 1999, 13:1561-1574.
326. Lim H., Paria B.C., Das S.K., et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997, 91:197-208.
327. Giess R., Tanasescu I., Steck T., et al. Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 1999, 5:581-586.
328. Robb L., Li R.L., Hartley L., et al. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998, 4:303-308.
329. Dimitriadis E., Robb L., Salamonsen L.A. Interleukin 11 advances progesterone-induced decidualization of human endometrial stromal cells. Mol Hum Reprod 2002, 8:636-643.
330. Dimitriadis E., Stoikos C., Baca M., et al. Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization. J Clin Endocrinol Metab 2005, 90:3458-3465.
331. Dimitriadis E., Stoikos C., Tan Y.L., et al. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation. Endocrinology 2006, 147:3809-3817.
332. Dimitriadis E., Sharkey A.M., Tan Y.L., et al. Immunolocalisation of phosphorylated STAT3, interleukin 11 and leukaemia inhibitory factor in endometrium of women with unexplained infertility during the implantation window. Reprod Biol Endocrinol 2007, 5:44.
333. Stewart E.A. Gonadotropins and the uterus: is there a gonad-independent pathway?. J Soc Gynecol Investig 2001, 8:319-326.
334. Lobo S.C., Srisuparp S., Peng X., et al. Uterine receptivity in the baboon: modulation by chorionic gonadotropin. Semin Reprod Med 2001, 19:69-74.
335. Fanchin R., Peltier E., Frydman R., et al. Human chorionic gonadotropin: does it affect human endometrial morphology in vivo?. Semin Reprod Med 2001, 19:31-35.
336. Licht P., Fluhr H., Newinger J., Wallweiner D., Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implementation?. Mol Cell Endocrinol 2007, 269:85-92.
337. Sugihara K., Kabir-Salmani M., Byrne J., et al. Induction of trophinin in human endometrial surface epithelia by CGbeta and IL-1beta. FEBS Lett 2007, 582:197-202.
338. Marions L., Danielsson K.G. Expression of cyclo-oxygenase in human endometrium during the implantation period. Mol Hum Reprod 1999, 5:961-965.
339. Li D.K., Liu L., Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003, 327:368.
340. Lim H., Dey S.K. A novel pathway of prostacyclin signaling-hanging out with nuclear receptors. Endocrinology 2002, 143:3207-3210.
341. Ding N.Z., Ma X.H., Diao H.L., et al. Differential expression of peroxisome proliferator-activated receptor delta at implantation sites and in decidual cells of rat uterus. Reproduction 2003, 125:817-825.
342. Matsumoto H., Ma W., Smalley W., et al. Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol Reprod 2001, 64:1557-1565.
343. Paria B.C., Wang H., Dey S.K. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. Chem Phys Lipids 2002, 121:201-210.
344. Habayeb O.M., Bell S.C., Konje J.C. Endogenous cannabinoids: metabolism and their role in reproduction. Life Sci 2002, 70:1963-1977.
345. Schuel H., Burkman L.J., Lippes J., et al. N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 2002, 121:211-227.
346. Maccarrone M., Bisogno T., Valensise H., et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 2002, 8:188-195.
347. Enders A.C., Welsh A.O. Structural interactions of trophoblast and uterus during hemochorial placenta formation. J Exp Zool 1993, 266:578-587.
348. Larsen J.F. Electron microscopy of nidation in the rabbit and observations on the human trophoblastic invasion. Ovo-Implantation, Human Gonadotrophins and Prolactin 1970, S. Karger, Basel, 38-51.
349. Bernirschke K., Kaufmann P., Bernirschke K., et al. Early development of the human placenta. Pathology of the Human Placenta 1991, Springer-Verlag, New York, 42-49.
350. Noyes R.W., Hertig A.I., Rock J. Dating the endometrial biopsy. Fertil Steril 1950, 1:3-25.
351. Lindenberg S. Experimental studies on the initial trophoblast endometrial interaction. Dan Med Bull 1991, 38:371-380.
352. Coutifaris C., Babalola G.O., Feinberg R.F., et al. Purified human cytotrophoblasts: surrogates for the blastocyst in in vitro models of implanation. Advances in Assisted Reproductive Technologies 1990, 687-695. Plenum Press, New York. S. Mashiach (Ed.).
353. Bentin-Ley U., Horn T., Sjîgren A., et al. Ultrastructure of human blastocyst-endometrial interactions in vitro. J Reprod Fertil 2000, 120:337-350.
354. Bentin-Ley U., Pedersen B., Lindenberg S., et al. Isolation and culture of human endometrial cells in a three-dimensional culture system. J Reprod Fertil 1994, 101:327-332.
355. Bentin-Ley U. Relevance of endometrial pinopodes for human blastocyst implantation. Hum Reprod 2000, (15(Suppl):67-73.
356. Yoshinaga K. Receptor concept in implantation research. Development of Preimplantation Embryos and their Environment 1989, 379-388. Alan Liss, New York. K. Yoshinaga, T. Mori (Eds.).
357. Lessey B.A., Damjanovich L., Coutifaris C., et al. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest 1992, 90:188-195.
358. Fukuda M.N., Sato T., Nakayama J., et al. Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation. Genes Dev 1995, 9:1199-1210.
359. Genbacev O.D., Prakobphol A., Foulk R.A., et al. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science 2003, 299:405-408.
360. Carson D.D., Julian J., Lessey B.A., et al. MUC1 is a scaffold for selectin ligands in the human uterus. Front Biosci 2006, 11:2903-2908.
361. Anderson T.L., Hoffman L.H. Alerations in epithelial glycocalyx of rabbit uteri during early pseudopregnancy and pregnancy and following ovariectomy. Am J Anat 1984, 171:321-334.
362. Peverini S., Kramer B. Superovulation affects glucosamine trisaccharides in the glycocalyx of the rat endometrium at the time of implantation. J Anat 1995, 187:487-490.
363. Aplin J.D. MUC-1 glycosylation in endometrium: possible roles of the apical glycocalyx at implantation. Hum Reprod 1999, 2)(14(Suppl):17-25.
364. DeSouza M.M., Surveyor G.A., Price R.E., et al. MUC1/episialin: a critical barrier in the female reproductive tract. J Reprod Immunol 1999, 45:127-158.
365. Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006, 12:731-746.
366. Donaghay M., Lessey B.A. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 2007, 25:461-475.
367. von Wolff M., Strowitzki T., Becker V., et al. Endometrial osteopontin, a ligand of β3-integrin, is maximally expressed around the time of the 'implantation' window. Fertil Steril 2001, 76:775.
368. Behzad F., Seif M.W., Campbell S., et al. Expression of two isoforms of CD44 in human endometrium. Biol Reprod 1994, 51:739-747.
369. Lessey B.A., Ilesanmi A.O., Sun J., et al. Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception, and infertility. Am J Reprod Immunol 1996, 35:195-204.
370. Campbell S., Swann H.R., Seif M.W., et al. Cell adhesion molecules on the oocyte and preimplantation human embryo. Hum Reprod 1995, 10:1571-1578.
371. Yelian F.D., Edgeworth N.A., Dong L.J., et al. Recombinant entactin promotes mouse primary trophoblast cell adhesion and migration through the Arg-Gly-Asp (RGD) recognition sequence. J Cell Biol 1993, 121:923-929.
372. Yelian F.D., Yang Y., Hirata J.D., et al. Molecular interactions between fibronectin and integrins during mouse blastocyst outgrowth. Mol Reprod Dev 1995, 41:435-448.
373. Illera M.J., Cullinan E., Gui Y., et al. Blockade of the alpha(v)beta(3) integrin adversely affects implantation in the mouse. Biol Reprod 2000, 62:1285-1290.
374. Illera M.J., Lorenzo P.L., Gui Y.T., et al. A role for alphavbeta3 integrin during implantation in the rabbit model. Biol Reprod 2003, 68:766-771.
375. Lai T.H., Shih Ie M., Vlahos N., et al. Differential expression of L-selectin ligand in the endometrium during the menstrual cycle. Fertil Steril 2005, 83(Suppl 1):1297-1302.
376. Foulk R.A., Zdravkovic T., Genbacev O., et al. Expression of L-selectin ligand MECA-79 as a predictive marker of human uterine receptivity. J Assist Reprod Genet 2007, 24:316-321.
377. Nikas G., Psychoyos A. Uterine pinopodes in peri-implantation human endometrium: clinical relevance. Ann N Y Acad Sci 1997, 816:129-142.
378. Enders A.C., Nelson D.M. Pinocytotic activity of the uterus of the rat. Am J Anat 1973, 138:277-299.
379. Murphy C.R. Understanding the apical surface markers of uterine receptivity: pinopods or uterodomes?. Hum Reprod 2000, 15:2451-2454.
380. Adams S.M., Gayer N., Hosie M.J., et al. Human uterodomes (pinopods) do not display pinocytotic function. Hum Reprod 2002, 17:1980-1986.
381. Lessey B.A., Gui Y., Apparao K.B., et al. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation. Mol Reprod Dev 2002, 62:446-455.
382. Lessey B.A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 2003, 68:809-815.
383. Kodaman P.H., Taylor H.S. Hormonal regulation of implantation. Obstet Gynecol Clin North Am 2004, 31:745-766.
384. Quinn C.E., Detmar J., Casper R.F. Pinopodes are present in Lif null and Hoxa10 null mice. Fertil Steril 2007, 88:1021-1028.
385. Usadi R.S., Murray M.J., Bagnell R.C., et al. Temporal and morphologic characteristics of pinopod expression across the secretory phase of the endometrial cycle in normally cycling women with proven fertility. Fertil Steril 2003, 79:970-974.
386. Acosta A.A., Elberger L., Borghi M., et al. Endometrial dating and determination of the window of implantation in healthy fertile women. Fertil Steril 2000, 73:788.
387. Quinn C., Ryan E., Claessens E.A., et al. The presence of pinopodes in the human endometrium does not delineate the implantation window. Fertil Steril 2007, 87:1015-1021.
388. Lessey B.A. The use of biomarkers for the assessment of uterine receptivity. Textbook of Assisted Reproductive Technology 2001, 353-366. Martin Dunitz, London. D.K. Gardner, A. Weissman, C.M. Howles, Z. Shoham (Eds.).
389. Cavagna M., Mantese J.C. Biomarkers of endometrial receptivity: a review. Placenta 2003, 24(Suppl B):S39-S47.
390. Nardo L.G., Bartoloni G., Di Mercurio S., et al. Expression of the alpha(v)beta3 and alpha4 beta1 integrins throughout the putative window of implantation in a cohort of healthy fertile women. Acta Obstet Gynecol Scand 2002, 81:753-758.
391. Nardo L.G., Nikas G., Makrigiannakis A., et al. Synchronous expression of pinopodes and alpha v beta 3 and alpha 4 beta 1 integrins in the endometrial surface epithelium of normally menstruating women during the implantation window. J Reprod Med 2003, 48:355-361.
392. Gonzalez R.R., Palomino A., Boric A., et al. A quantitative evaluation of α1, α4, αV and 3 endometrial integrins of fertile and unexplained infertile women during the menstrual cycle. A flow cytometric appraisal. Hum Reprod 1999, 14:2485-2492.
393. Ordi J., Creus M., Ferrer B., et al. Midluteal endometrial biopsy and alphavbeta3 integrin expression in the evaluation of the endometrium in infertility: implications for fecundity. Int J Gynecol Pathol 2002, 21:231-238.
394. Thomas K., Thomson A.J., Sephton V., et al. The effect of gonadotrophic stimulation on integrin expression in the endometrium. Hum Reprod 2002, 17:63-68.
395. Creus M., Balasch J., Ordi J., et al. Integrin expression in normal and out-of-phase endometria. Hum Reprod 1998, 13:3460-3468.
396. Carson D.D., Lagow E., Thathiah A., et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod 2002, 8:871-879.
397. Talbi S., Hamilton A.E., Vo K.C., et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006, 147:1097-1121.
398. Kao L.C., Tulac S., Lobo S., et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002, 143:2119-2138.
399. Riesewijk A., Martin J., van Os R., et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 2003, 9:253-264.
400. Eyster K.M., Klinkova O., Kennedy V., et al. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril 2007, 88:1505-1533.
401. Mettler L., Salmassi A., Schollmeyer T., et al. Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis). J Assist Reprod Genet 2007, 24:249-258.
402. Matsuzaki S., Canis M., Pouly J.L., et al. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertil Steril 2006, 86:548-553.
403. Wu Y., Kajdacsy-Balla A., Strawn E., et al. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology 2006, 147:232-246.
404. Matsuzaki S., Canis M., Vaurs-Barriere C., et al. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod 2004, 10:719-728.
405. Murray M.J., Meyer W.R., Zaino R.J., et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril 2004, 81:1333-1343.
406. Fritz M.A., Lessey B.A. Defective luteal function. Estrogens and Progestogens in Clinical Practice 1998, vol 1:437-494. Churchhill Livingstone, London. I.S. Fraser (Ed.).
407. Fritz M.A. Inadequate luteal function and recurrent abortion: diagnosis and treatment of luteal phase deficiency. Semin Reprod Endocrinol 1988, 6:129-144.
408. Myers E.R., Silva S., Barnhart K., et al. Interobserver and intraobserver variability in the histological dating of the endometrium in fertile and infertile women. Fertil Steril 2004, 82:1278-1282.
409. Batista M.C., Cartledge T.P., Merino M.J., et al. Midluteal phase endometrial biopsy does not accurately predict luteal function. Fertil Steril 1993, 59:294-300.
410. Coutifaris C., Myers E.R., Guzick D.S., et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril 2004, 82:1264-1272.
411. Shoupe D., Mishell D.R., Lacarra M., et al. Correlation of endometrial maturation with four methods of estimating day of ovulation. Obstet Gynecol 1989, 73:88-92.
412. Lessey B.A., Young S.L., Larson S.F., et al. Characterization of Mig-6 expression in normal and PCOS endometrium suggests a mechanism for endometrial hyperplasia and cancer. Reprod Sci 2008, 15. 316A 911.
413. Taylor H.S., Bagot C., Kardana A., et al. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 1999, 14:1328-1331.
414. Jackson K.S., Brudney A., Hastings J.M., et al. The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity. Reprod Sci 2007, 14:137-150.
415. Taylor E., Gomel V. The uterus and fertility. Fertil Steril 2008, 89:1-16.
416. Amso N.N., Griffiths A. The role and applications of ultrasound in ambulatory gynaecology. Best Pract Res Clin Obstet Gynaecol 2005, 19:693-711.
417. Bassil S. Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization. Ultrasound Obstet Gynecol 2001, 18:258-263.
418. Gonen Y., Calderon I., Dirnfeld M., et al. The impact of sonographic assessment of the endometrium and meticulous hormonal monitoring during natural cycles in patients with failed donor artificial insemination. Ultrasound Obstet Gynecol 1991, 1:122-126.
419. Ohno Y., Hosokawa K., Tamura T., et al. Endometrial oestrogen and progesterone receptors and their relationship to sonographic endometrial appearance. Hum Reprod 1995, 10:708-711.
420. Puerto B., Creus M., Carmona F., et al. Ultrasonography as a predictor of embryo implantation after in vitro fertilization: a controlled study. Fertil Steril 2003, 79:1015-1022.
421. Sterzik K., Grab D., Schneider V., et al. Lack of correlation between ultrasonography and histologic staging of the endometrium in in vitro fertilization (IVF) patients. Ultrasound Med Biol 1997, 23:165-170.
422. Battaglia C., Sgarbi L., Salvatori M., et al. Increased anticardiolipin antibodies are positively related to the uterine artery pulsatility index in unexplained infertility. Hum Reprod 1998, 13:3487-3491.
423. Habara T., Nakatsuka M., Konishi H., et al. Elevated blood flow resistance in uterine ateries of women with unexplained recurrent pregnancy loss. Hum Reprod 2002, 17:190-194.
424. Carbillon L., Perrot N., Uzan M., et al. Doppler ultrasonography and implantation: a critical review. Fetal Diagn Ther 2001, 16:327-332.
425. Goldstein S.R. Controversy about uterine effects and safety of SERMs: the saga continues. Menopause 2002, 9:381-384.
426. Maymon R., Herman A., Ariely S., et al. Three-dimensional vaginal sonography in obstetrics and gynaecology. Hum Reprod Update 2000, 6:475-484.
427. Alcazar J.L. Three-dimensional ultrasound assessment of endometrial receptivity: a review. Reprod Biol Endocrinol 2006, 4:56.
428. van Dongen H., de Kroon C.D., Jacobi C.E., et al. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2007, 114:664-675.
429. Jansen F.W., Vredevoogd C.B., van Ulzen K., et al. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol 2000, 96:266-270.
430. Phillips K. Hysteroscopic sterilisation: is laparoscopic sterilisation a thing of the past?. BJOG 2007, 114:661-663.
431. Silverberg S.G. The endometrium. Arch Pathol Lab Med 2007, 131:372-382.
432. Sherman M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000, 13:295-308.
433. Studd J.W., Thom M., Patterson M. Oestrogen therapy and endometrial carcinoma. Lancet 1979, 1:1239.
434. Hardiman P., Pillay O.C., Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003, 361:1810-1812.
435. Pillay O.C., Te Fong L.F., Crow J.C., et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006, 21:924-929.
436. MacLaughlin S.D., Palomino W.A., Mo B., et al. Endometrial expression of Cyr61: a marker of estrogen activity in normal and abnormal endometrium. Obstet Gynecol 2007, 110:146-154.
437. Jin N., Gilbert J.L., Broaddus R.R., et al. Generation of a Mig-6 conditional null allele. Genesis 2007, 45:716-721.
438. Whitehead M.I., Fraser D. The effects of estrogens and progestogens on the endometrium. Modern approach to treatment. Obstet Gynecol Clin North Am 1987, 14:299-320.
439. De Vivo I., Huggins G.S., Hankinson S.E., et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc Natl Acad Sci U S A 2002, 99:12263-12268.
440. Kanamori Y., Kigawa J., Itamochi H., et al. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin Cancer Res 2001, 7:892-895.
441. Simpkins S.B., Peiffer-Schneider S., Mutch D.G., et al. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol 1998, 71:391-395.
442. Wang H., Douglas W., Lia M., et al. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am J Pathol 2002, 160:1481-1486.
443. Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006, 12:731-746.
444. Conneely O.M., Mulac-Jericevic B., DeMayo F., et al. Reproductive functions of progesterone receptors. Recent Prog Horm Res 2002, 57:339-355.
445. Croxatto H.B. Physiology of gamete and embryo transport through the fallopian tube. Reprod Biomed Online 2002, 4:160-169.
446. Donaghay M., Lessey B.A. Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 2007, 25:461-475.
447. King A. Uterine leukocytes and decidualization. Hum Reprod Update 2000, 6:28-36.
448. Leese H.J., Tay J.I., Reischl J., et al. Formation of fallopian tubal fluid: role of a neglected epithelium. Reproduction 2001, 121:339-346.
449. Morcel K., Camborieux L., Guerrier D. Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Orphanet J Rare Dis 2007, 2:13.
450. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
451. Paria B.C., Reese J., Das S.K., et al. Deciphering the cross-talk of implantation: advances and challenges. Science 2002, 296:2185-2188.
452. Seppala M., Taylor R.N., Koistinen H., et al. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 2002, 23:401-430.
453. Silverberg S.G. The endometrium. Arch Pathol Lab Med 2007, 131:372-382.
454. Slayden O.D., Keator C.S. Role of progesterone in nonhuman primate implantation. Semin Reprod Med 2007, 25:418-430.
455. Wang H., Dey S.K. Roadmap to embryo implantation:clues from mouse models. Nature Rev Genetics 2006, 7:185-199.